Related Experiment Video
Updated: Oct 31, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort
Francesc Escrihuela-Vidal1, Luis Eduardo López-Cortés2, Laura Escolà-Vergé3,4
1Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut d´Investigació Biomèdica de Bellvitg e, University of Barcelona, Barcelona, Spain.
Insights
Streptococcus anginosus group (SAG) endocarditis is uncommon but serious, with outcomes similar to viridans group streptococci (VGS) or Streptococcus gallolyticus group (SGG) endocarditis. This study found no significant differences in complications or mortality between SAG and VGS/SGG infections.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Streptococcus anginosus group (SAG) endocarditis is often presumed severe, linked to abscesses and emboli.
- Limited evidence currently supports the severity assumption for SAG endocarditis.
Purpose of the Study:
- To evaluate the clinical presentation and outcomes of SAG endocarditis.
- To compare SAG endocarditis with viridans group streptococci (VGS) and Streptococcus gallolyticus group (SGG) endocarditis.
Main Methods:
- Retrospective analysis of prospectively collected data from 72 patients with definite SAG endocarditis.
- Matched comparison (1:2) with 144 patients with VGS or SGG endocarditis across 28 centers in Spain and Italy.
Main Results:
- SAG endocarditis was community-acquired, frequently affecting the aortic native valve.
- No significant differences were observed in septic shock, valve disorders, paravalvular complications, heart failure, or embolic events between SAG and VGS/SGG groups.
- Surgical indications and mortality rates were similar between the SAG and VGS/SGG groups.
Conclusions:
- SAG endocarditis is an infrequent but serious condition.
- The prognosis of SAG endocarditis is comparable to that of VGS/SGG endocarditis.
Background:
Although Streptococcus anginosus group (SAG) endocarditis is considered a severe disease associated with abscess formation and embolic events, there is limited evidence to support this assumption.
Methods:
We performed a retrospective analysis of prospectively collected data from consecutive patients with definite SAG endocarditis in 28 centers in Spain and Italy. A comparison between cases due to SAG endocarditis and viridans group streptococci (VGS) or Streptococcus gallolyticus group (SGG) was performed in a 1:2 matched analysis.
Results:
Of 5336 consecutive cases of definite endocarditis, 72 (1.4%) were due to SAG and matched with 144 cases due to VGS/SGG. SAG endocarditis was community acquired in 64 (88.9%) cases and affected aortic native valve in 29 (40.3%). When comparing SAG and VGS/SGG endocarditis, no significant differences were found in septic shock (8.3% vs 3.5%, P = .116); valve disorder, including perforation (22.2% vs 18.1%, P = .584), pseudoaneurysm (16.7% vs 8.3%, P = .108), or prosthesis dehiscence (1.4% vs 6.3%, P = .170); paravalvular complications, including abscess (25% vs 18.8%, P = .264) and intracardiac fistula (5.6% vs 3.5%, P = .485); heart failure (34.7% vs 38.9%, P = .655); or embolic events (41.7% vs 32.6%, P = .248). Indications for surgery (70.8% vs 70.8%; P = 1) and mortality (13.9% vs 16.7%; P = .741) were similar between groups.
Conclusions:
SAG endocarditis is an infrequent but serious condition that presents a prognosis similar to that of VGS/SGG.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests

